gvtcx

Provision of Testing Services and Sample Analysis as part of the National Immunisation Programme

Public Health England Published 13 Mar 2021 Contracts Finder

key details

Value£240,000
Statuscomplete
Category (CPV) 71900000
Deadline9 Feb 2021
Contract start9 Feb 2021
Contract end17 Jan 2023
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-02afcef5-763f-4948-b450-bd8b0c781d68

Award

SupplierValueDateStatus
Oxford Immunotec Ltd £240,000 9 Feb 2021 active

description

PHE has been tasked by DHSC to urgently undertake a study to evaluate the immune response following COVID-19 vaccines as part of the National Immunisation Programme. This has been identified as a high national public health priority and a key aspect of this study requires taking 2000 samples for cellular work over a 24-month period. The UK Vaccines Taskforce have selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Aligning PHE's study with this decision will ensure that it is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
13 Mar 2021 Award (award) · 53b61254-c135-48ae-9970-7e88c38473c7-420030

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.